Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03416179
Title A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia (BRIGHT AML1019)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications

acute myeloid leukemia

Therapies

Cytarabine

Cytarabine + Daunorubicin + Glasdegib

Azacitidine + Glasdegib

Azacitidine

Cytarabine + Daunorubicin

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.